Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Wyld Issues Convertible Loan Notes

7 May 2020 07:00

Tern PLC (TERN) Wyld Issues Convertible Loan Notes 07-May-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

7 May 2020

Tern Plc ("Tern" or the "Company")

Wyld Networks Limited issues of £400,000 of Convertible Loan Notes to third party

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that its portfolio company, Wyld Networks Limited ("Wyld"), has secured £400,000 from an investor to fund its growing pipeline of opportunities and for general working capital purposes, by way of an unsecured Convertible Loan Note facility ("CLN"). The CLN has been issued in full. The CLN also includes an option to convert into Tern shares under certain circumstances.

 

Tern's CEO, Al Sisto, said:

"Wyld has gone from strength to strength over the past 12 months and this external investment is a huge vote of confidence in Wyld's management team, which has transformed this start up business and its pipeline in a very short space of time. This external investment is from an investor who is seeking exposure to the mid- to long-term growth opportunities presented by IoT innovation and to have received its additional support early in the development of Wyld is very validating. With contracts signed to provide IoT solutions, a cooperation agreement with one of the world's largest satellite operators secured and its technology now patent pending, Wyld has reached an important point in its development. These funds will enable Wyld to continue on this upward trajectory towards the goal of securing a syndicated Series A funding round in due course."

 

The CLN, which bears interest at 5% per annum, is convertible into Wyld shares, at the option of the investor ("CLN Holder"), at either 25%, 50%, 75% or 100% of the principal of the CLN, on completion of an exit or Wyld equity fundraise of at least £1 million from a third party (in both cases) other than Tern before 6 May 2021 (the "Maturity Date"). This conversion would take place at a 20% discount to the Wyld equity fundraise price or the exit price per Wyld share.

 

Following a conversion event, any amount of the CLN not converted into Wyld shares will automatically be converted into fully paid ordinary shares of 0.02 p each in the capital of Tern ("Tern Shares") at a 15% discount to the market price of Tern Shares on AIM at market close on the date of the conversion event.  

 

If a conversion event has not occurred by the Maturity Date, then the CLN Holder has the option to elect to convert all of the CLN into Tern Shares at a 15% discount to the five-day average closing price of Tern Shares on AIM immediately prior to the Maturity Date, or, failing such election, the maturity date of the CLN is to be extended for one further year ("the Second Maturity Date"). If a Conversion Event has not taken place by the Second Maturity Date, the CLN will automatically convert into fully paid Tern Shares at a 15% discount to the five-day average closing price of Tern Shares on AIM immediately prior to the Second Maturity Date.

 

Under the terms of the CLN, the CLN Holder has to enter into an orderly market deed ("the Orderly Market Deed") before any issue of Tern Shares can be effected. Under the Orderly Market Deed, the CLN Holder would undertake (subject to customary carve-outs from such restrictions):

 

not to dispose of any interests in such Tern Shares issued and allotted following a Conversion Event for a period of one month following such Conversion Event; not to dispose of any interests in 50% of all such Tern Shares issued and allotted following a Conversion Event for a period of three-months following such Conversion Event; following expiry of the period referred to in paragraph (b), up to the date that is six months following such Conversion Event, not to dispose of any interests in any remaining Tern Shares issued and allotted following such Conversion Event, other than through Tern's nominated adviser (or any nominated adviser or broker appointed to act for Tern in place of the nominated adviser) subject to the terms relating to the price and execution offered by the nominated adviser being materially no less favourable than other brokers at that time; and to use all reasonable endeavours to ensure that its associates comply with the restrictions contained in such undertaking.

The CLN is not transferable other than with the prior consent of Wyld and Tern and is subject to customary terms and conditions for such an instrument.

Enquiries

Tern Plc

Al Sisto/Sarah Payne

via Newgate Communications

 

Allenby Capital

(Nomad and joint broker)

David Worlidge/Alex Brearley

 

Tel: 020 3328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

Tel: 020 7659 1234

 

Newgate Communications

Elisabeth Cowell/Megan Kovach

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCU
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:62205
EQS News ID:1038099
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th Dec 20247:01 amRNS-ROnline Investor Presentation and Q&A Session
16th Dec 20247:00 amRNSPlacing to raise £400,000
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSBoard Changes
25th Oct 20248:27 amRNSFurther re. Wyld Networks Rights Issue
15th Oct 20247:00 amRNSPlacing to raise £625,000
30th Sep 20245:04 pmRNSTotal Voting Rights
30th Sep 20247:00 amRNSDevice Authority Update
23rd Sep 202411:13 amRNSReplacement: Results of Open Offer
23rd Sep 202411:10 amRNSResult of General Meeting
23rd Sep 20247:00 amRNSResults of Open Offer
5th Sep 20247:00 amRNSOpen Offer and Notice of General Meeting
5th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
2nd Sep 202410:16 amRNSStatement re Wyld Networks Rights Issue
9th Aug 20247:00 amRNSPartial sale of Device Authority holding
27th Jun 202412:00 pmRNSResult of AGM
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResults for the year ended 31 December 2023
15th May 20247:00 amRNSExercise of Warrants
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.